PCOS Renamed to PMOS: Understanding the Hormonal Syndrome Affecting Millions
Polycystic ovary syndrome (PCOS) has been renamed to polyendocrine metabolic ovarian syndrome (PMOS), reflecting updated understanding of the condition. PMOS is a common hormonal disorder affecting over 170 million people of reproductive age worldwide, including up to 12% of U.S. women. The condition has wide-ranging effects on metabolism, appearance, mental health, and fertility, making the name change medically significant.
PCOS, a common hormonal disorder in females, has been officially renamed to polyendocrine metabolic ovarian syndrome (PMOS) to better reflect the condition's broader systemic effects. The condition affects over 170 million people of reproductive age globally, with prevalence reaching up to 12% among U.S. women of reproductive age. PMOS is characterized by a buildup of underdeveloped eggs in the ovaries and has wide-ranging impacts on the body, including effects on metabolism, hair growth, skin health, and mental well-being. The condition can also affect fertility and reproductive outcomes. The name change appears to acknowledge that PMOS involves multiple endocrine and metabolic systems beyond just ovarian dysfunction, providing a more accurate clinical description of the syndrome's complexity.
What's missing
The article does not explain when or why the name change occurred, what medical organizations officially endorsed it, or whether the change is universally adopted across healthcare systems. Additionally, it lacks information about the specific symptoms, diagnostic criteria, or treatment options for PMOS/PCOS.
How coverage differed
The Live Science article presents the name change as an established fact without discussing the controversy or timeline of adoption. Other medical sources may vary in whether they use the new PMOS terminology or traditional PCOS naming, reflecting different institutional adoption rates of the nomenclature change.
What different sources said
- Live ScienceCenter
What is PMOS (formerly PCOS)? What to know about the hormonal syndrome
Related
Meta-analysis finds depressive mood sharpens self-judgment while impairing social perception
A large meta-analysis found that depressive mood affects different types of judgment differently—enhancing self-focused judgment while impairing the ability to read social cues. The study, conducted by researchers at Lingnan University, analyzed the relationship between depressive mood and reality judgment across multiple studies. This distinction matters because it challenges the assumption that depression uniformly distorts all judgment and suggests more nuanced cognitive effects.
Study Examines How Extreme Heat Impacts Cancer Care Decisions in South Florida
A new study reveals that extreme heat in South Florida significantly influences how people with cancer manage their daily care and treatment decisions. The research highlights how environmental factors like heat create additional health burdens beyond cancer itself for patients in the region. Understanding these connections is important for developing more comprehensive cancer care strategies that account for climate and environmental stressors.
Consumer Reports Releases 2025 Sunscreen Recommendations After Testing 51 Products
Consumer Reports lab-tested 51 sunscreens and released its top recommendations for 2025, with Coppertone Water Babies lotion SPF 50 ranking as the best overall option. The testing evaluated both chemical and mineral sunscreens, with lotion formulations preferred over sprays due to better visibility of application amounts. The findings emphasize year-round sunscreen use and proper application techniques to maximize UV protection.